Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Dynamyx Digital Pathology Software

K-Number: K210811 · 2022-03-01

Decision Date2022-03-01
Product CodeQKQ
Advisory CommitteePA
DecisionSubstantially Equivalent

Device Summary

Dynamyx Digital Pathology Software is the device name listed in this FDA 510(k) record. The listed applicant is Inspirata, Inc.. It received FDA 510(k) clearance on 2022-03-01 under 510(k) number K210811. The device is classified under product code QKQ. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Dynamyx Digital Pathology Software?

Dynamyx Digital Pathology Software is a medical device that received FDA 510(k) clearance on 2022-03-01. The listed applicant is Inspirata, Inc.. The 510(k) number is K210811.

When did Dynamyx Digital Pathology Software receive FDA 510(k) clearance?

Dynamyx Digital Pathology Software received FDA 510(k) clearance on 2022-03-01, under 510(k) number K210811.

Who is the listed applicant for Dynamyx Digital Pathology Software?

The FDA 510(k) record lists Inspirata, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Dynamyx Digital Pathology Software?

The FDA product code for Dynamyx Digital Pathology Software is QKQ.

Related Devices (Code: QKQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.